Anti-angiogenesis therapy, a promising strategy against cancer progression, is limited by
drug-resistance, which could be attributed to changes within the tumor microenvironment …

Angiogenesis is a vital process for the growth and dissemination of solid cancers. Numerous
molecular pathways are known to drive angiogenic switch in cancer cells promoting the …

Lung cancer is a main cause of death all over the world with a high incidence rate.
Metastasis into neighboring and distant tissues as well as resistance of cancer cells to …

Vessel co-option is an alternative strategy by which tumour cells vascularize and gain
access to nutrients to support tumour growth, survival and metastasis. In vessel co-option …

Background and aims The intake of Processed foods/junk foods/preserved foods are
commonly seen in the majority of individuals all over the globe. The chemical composition or …

Lung cancer, as a malignant tumor with both high incidence and mortality in China, is one of
the major causes of death in our population and one of the major public health problems in …

Antiangiogenic therapy targeting VEGF‐A has become the standard of first‐line therapy for
non‐small cell lung cancer (NSCLC). However, its clinical response rate is still less than …

During tumor development, the tumor itself must continuously generate new blood vessels to
meet their growth needs while also allowing for tumor invasion and metastasis. One of the …

A particular type of tumor that is frequently detected in female dogs who are sexually active
is a mammary tumor. Neoplasia results from DNA-based alterations in cell cycle regulating …

Angiogenesis is a complex physiological process. In recent years, the immune regulation of
angiogenesis has received increasing attention, and innate immune cells, which are centred …